Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-14534
Neuropharmacology 1998 Jan 01;373:391-6. doi: 10.1016/s0028-3908(98)00021-5.
Show Gene links Show Anatomy links

Colchicine competitively antagonizes glycine receptors expressed in Xenopus oocytes.

Machu TK .


???displayArticle.abstract???
Ligand-gated ion channel association with the cytoskeleton may play an important role in receptor distribution and function. However, the microtubule depolymerizing agent, colchicine, has inhibitory effects on glycine receptors that are independent of microtubule depolymerization. The actions of colchicine and other microtubule-modifying drugs were examined on glycine alpha1 and alpha2 receptors expressed in Xenopus oocytes. The potency of colchicine was much greater in alpha2 than alpha1 receptors, with IC50s of approximately 64 and 324 microM in alpha2 and alpha1 receptors, respectively. Colchicine inhibition of receptor function was instantaneous. Pre-incubation with colchicine failed to enhance its inhibition, and washout of colchicine's inhibition could be observed in 30 s. Incubation of oocytes on ice for 2 h to depolymerize microtubules failed to alter colchicine's antagonism of glycine receptors. Taxol, a microtubule polymerizing agent, and nocodazole, a depolymerizing drug, had no effect on receptor function when co-applied with glycine. The antagonism of glycine-mediated currents by colchicine (100-600 microM) was competitive. Thus, the action of colchicine at the agonist recognition site of the glycine receptor suggests that this drug should be used with care when studying microtubule-associated changes in ligand-gated ion channel function.

???displayArticle.pubmedLink??? 9681937
???displayArticle.link??? Neuropharmacology
???displayArticle.grants??? [+]